secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001193125-24-053689
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte registers 1.68M shares for resale related to C2i Genomics acquisition
------------------------------------------------------------------------------

- Filed prospectus supplement to register up to 1,681,384 shares of common stock for resale.
- Shares were issued in connection with the acquisition of C2i Genomics, Inc. on Feb 5, 2024.
- Includes opinion of counsel (Fenwick & West) on legality of the shares.
- This is a procedural step; no new financial or operational information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000119312524053689/0001193125-24-053689-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000119312524053689/d799495d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-053689

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer